Interruption of specific guanylyl cyclase signaling pathways.
Gao
Z
Z
Howard Hughes Medical Institute and Department of Pharmacology, The University of Texas Southwestern Medical Center at Dallas, 75235, USA.
Yuen
P S
PS
Garbers
D L
DL
D000595:Amino Acid Sequence; D000818:Animals; D001427:Bacterial Toxins / Q000494:pharmacology; D006152:Cyclic GMP / Q000378:metabolism; D004768:Enterotoxins / Q000494:pharmacology; D029968:Escherichia coli Proteins; D006162:Guanylate Cyclase / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000235:genetics; D066298:In Vitro Techniques; D007340:Insulinoma / Q000235:genetics / Q000378:metabolism; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism; D008969:Molecular Sequence Data; D009599:Nitroprusside / Q000494:pharmacology; D010190:Pancreatic Neoplasms / Q000235:genetics / Q000378:metabolism; D017354:Point Mutation; D012333:RNA, Messenger / Q000235:genetics; D051381:Rats; D017384:Sequence Deletion; D015398:Signal Transduction; D014162:Transfection; D014407:Tumor Cells, Cultured
D001427:Bacterial Toxins; D004768:Enterotoxins; D029968:Escherichia coli Proteins; D012333:RNA, Messenger; C034151:heat stable toxin (E coli); D009599:Nitroprusside; D006162:Guanylate Cyclase; D006152:Cyclic GMP